Clinical Trial Update: Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 chemotherapy trial for recurrent, metastatic, or unresectable ovarian, fallopian tube, or primary peritoneal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Chemotherapy regimen (unspecified)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: COMPLETED